BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9697979)

  • 21. Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field.
    Brant SR; Shugart YY
    Inflamm Bowel Dis; 2004 May; 10(3):300-11. PubMed ID: 15290927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16.
    Curran ME; Lau KF; Hampe J; Schreiber S; Bridger S; Macpherson AJ; Cardon LR; Sakul H; Harris TJ; Stokkers P; Van Deventer SJ; Mirza M; Raedler A; Kruis W; Meckler U; Theuer D; Herrmann T; Gionchetti P; Lee J; Mathew C; Lennard-Jones J
    Gastroenterology; 1998 Nov; 115(5):1066-71. PubMed ID: 9797359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease].
    Kim TH; Kim BG; Shin HD; Kim JW; Kim CG; Kim JS; Jung HC; Song IS
    Korean J Gastroenterol; 2003 Nov; 42(5):377-86. PubMed ID: 14646574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Polymorphism rs3024505 (C/T) Downstream of the IL10 Gene Is Associated with Crohn's Disease in Serbian Patients with Inflammatory Bowel Disease.
    Mijac D; Petrovic IV; Djuranovic S; Perovic V; Bojic D; Culafic D; Popovic D; Krstic M; Jankovic G; Djoric M; Pravica V; Markovic M
    Tohoku J Exp Med; 2016 Sep; 240(1):15-24. PubMed ID: 27558476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms.
    Balding J; Livingstone WJ; Conroy J; Mynett-Johnson L; Weir DG; Mahmud N; Smith OP
    Mediators Inflamm; 2004 Jun; 13(3):181-7. PubMed ID: 15223609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on inflammatory bowel disease genetics.
    Cho J
    Curr Gastroenterol Rep; 2000 Dec; 2(6):434-9. PubMed ID: 11079043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease.
    Naom I; Lee J; Ford D; Bowman SJ; Lanchbury JS; Haris I; Hodgson SV; Easton D; Lennard-Jones J; Mathew CG
    Am J Hum Genet; 1996 Jul; 59(1):226-33. PubMed ID: 8659528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.
    Márquez A; Orozco G; Martínez A; Palomino-Morales R; Fernández-Arquero M; Mendoza JL; Taxonera C; Díaz-Rubio M; Gómez-García M; Nieto A; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
    Am J Gastroenterol; 2009 Aug; 104(8):1968-75. PubMed ID: 19471255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6.
    Fisher SA; Hampe J; Macpherson AJ; Forbes A; Lennard-Jones JE; Schreiber S; Curran ME; Mathew CG; Lewis CM
    Eur J Hum Genet; 2002 Apr; 10(4):259-65. PubMed ID: 12032734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
    Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
    Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease.
    Olavesen MG; Hampe J; Mirza MM; Saiz R; Lewis CM; Bridger S; Teare D; Easton DF; Herrmann T; Scott G; Hirst J; Sanderson J; Hodgson SV; Lee J; MacPherson A; Schreiber S; Lennard-Jones JE; Curran ME; Mathew CG
    Immunogenetics; 2000 Jan; 51(1):1-7. PubMed ID: 10663555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci.
    Paavola-Sakki P; Ollikainen V; Heliö T; Halme L; Turunen U; Lahermo P; Lappalainen M; Färkkilä M; Kontula K
    Eur J Hum Genet; 2003 Feb; 11(2):112-20. PubMed ID: 12634858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.
    Ohmen JD; Yang HY; Yamamoto KK; Zhao HY; Ma Y; Bentley LG; Huang Z; Gerwehr S; Pressman S; McElree C; Targan S; Rotter JI; Fischel-Ghodsian N
    Hum Mol Genet; 1996 Oct; 5(10):1679-83. PubMed ID: 8894707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
    Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U
    Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16.
    Rioux JD; Daly MJ; Green T; Stone V; Lander ES; Hudson TJ; Steinhart AH; Bull S; Cohen Z; Greenberg G; Griffiths A; McLeod R; Silverberg M; Williams CN; Siminovitch KA
    Gastroenterology; 1998 Nov; 115(5):1062-5. PubMed ID: 9797358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson NH; Noble CL; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    Gut; 2006 Aug; 55(8):1114-23. PubMed ID: 16469794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease.
    Tagore A; Gonsalkorale WM; Pravica V; Hajeer AH; McMahon R; Whorwell PJ; Sinnott PJ; Hutchinson IV
    Tissue Antigens; 1999 Oct; 54(4):386-90. PubMed ID: 10551422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.